ACRS vs CAMP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACRS Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aclaris Therapeutics, Inc. (ACRS) driven by superior Momentum & Technical, Options & Structure while CAMP counters with relative strength in Growth & Margin. Fundamentally, ACRS trades at N/M Forward P/E with -1412.4% operating margin (-55.1% YoY revenue) versus CAMP at N/M Forward P/E and -991.8% operating margin (+138.9% YoY). In options structure, ACRS sits in BREAKDOWN (1st %ile IV; Dealer Gamma Walls on Pro) against CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ACRS Revenue | CAMP Revenue | ACRS Op. Margin | CAMP Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $10M | N/A | -1378.3% | N/A | ACRS |
| FY2019 | $0M | N/A | -2627.3% | N/A | ACRS |
| FY2020 | $10M | N/A | -785.4% | N/A | ACRS |
| FY2021 | $10M | N/A | -1327.1% | N/A | ACRS |
| FY2022 | $30M | N/A | -302.0% | N/A | ACRS |
| FY2023 | $30M | $0M | -311.6% | -14822.6% | ACRS |
| FY2024 | $20M | $0M | -758.2% | -8142.3% | ACRS |
| FY2025 | $10M | $0M | -975.9% | -1502.4% | ACRS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACRS | CAMP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $621.8M | $238.5M | Larger Scale | ACRS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -55.1% | +138.9% | Higher Growth | CAMP |
| Operating Margin (TTM) Profitability | -1412.4% | -991.8% | Higher Margin | CAMP |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -55.5% | -146.1% | Higher ROE | ACRS |
| 52-Week Range Position Momentum | 25% ($2โ$7) | 23% ($3โ$8) | Stronger Trend | ACRS |
| Beta / 30D Volatility Risk Regime | 1.56ฮฒ ยท 74% Vol | 1.35ฮฒ ยท 94% Vol | Lower Realized Risk | ACRS |
| Unified Institutional Score Composite Signal | 44.7 / 100 (HOLD) | 43.9 / 100 (HOLD) | Higher Composite | ACRS |